Avenue Therapeutics Inc (NAS:ATXI) Stock News, Headlines & Updates
Avenue Therapeutics Inc Stock News from GuruFocus
- 1
Jun 20, 2024
Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
Marketwired • 8:00am
May 16, 2024
Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
Marketwired • 8:00am
May 15, 2024
Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Marketwired • 8:00am
Apr 29, 2024
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
Marketwired • 8:00am
Apr 24, 2024
Avenue Therapeutics Announces Reverse Stock Split
Marketwired • 7:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news